Cargando…

A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease

Gaucher disease (GD), the most common lysosomal storage disorders, is caused by GBA gene mutations resulting in glycosphingolipids accumulations in various tissues, such as the brain. While suppressing glycosphingolipid accumulation is the central strategy for treating peripheral symptoms of GD, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Takahiro, Tanaka, Yuta, Oki, Hideyuki, Sato, Sho, Shibata, Sachio, Maru, Takamitsu, Tanaka, Maiko, Onishi, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293090/ https://www.ncbi.nlm.nih.gov/pubmed/34398463 http://dx.doi.org/10.1111/jnc.15492

Ejemplares similares

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease
por: Marshall, John, et al.
Publicado: (2016)

A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice
por: Onishi, Tomohiro, et al.
Publicado: (2021)

Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
por: Barnes, Sonya, et al.
Publicado: (2014)

Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease
por: Cabrera-Salazar, Mario A., et al.
Publicado: (2012)

Glucosylceramide synthase maintains influenza virus entry and infection
por: Drews, Kelly, et al.
Publicado: (2020)

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020)

ARF6 Regulates Neuron Differentiation through Glucosylceramide Synthase
por: Li, Lu, et al.
Publicado: (2013)

New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression
por: Gupta, Vineet, et al.
Publicado: (2013)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Glucosylceramide Associated with Gaucher Disease Forms Amyloid-like Twisted Ribbon Fibrils That Induce α-Synuclein Aggregation
por: Paul, Ashim, et al.
Publicado: (2021)

Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
por: Nicholson, K M, et al.
Publicado: (1999)

Doxorubicin Influences the Expression of Glucosylceramide Synthase in Invasive Ductal Breast Cancer
por: Zhang, Xiaofang, et al.
Publicado: (2012)

Control of Glucosylceramide Production and Morphogenesis by the Bar1 Ceramide Synthase in Fusarium graminearum
por: Rittenour, William R., et al.
Publicado: (2011)

Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
por: Henriques, Alexandre, et al.
Publicado: (2015)

Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma
por: Stefanovic, Milica, et al.
Publicado: (2016)

Glucosylceramide synthase deficiency in the heart compromises β1-adrenergic receptor trafficking
por: Andersson, Linda, et al.
Publicado: (2021)

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
por: Baccam, Gabriel C., et al.
Publicado: (2022)

Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system
por: Avraham, Roy, et al.
Publicado: (2023)

Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus
por: Vitner, Einat B., et al.
Publicado: (2021)

Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model
por: Viel, Catherine, et al.
Publicado: (2021)

The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation
por: Hartwig, Pia, et al.
Publicado: (2021)

Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry
por: Dei Cas, Michele, et al.
Publicado: (2023)

Human Glucosylceramide Synthase at Work as Provided by “In Silico” Molecular Docking, Molecular Dynamics, and Metadynamics
por: Canini, Giorgia, et al.
Publicado: (2023)

Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide Synthase
por: Yew, Nelson S., et al.
Publicado: (2010)

Neuronal Expression of Glucosylceramide Synthase in Central Nervous System Regulates Body Weight and Energy Homeostasis
por: Nordström, Viola, et al.
Publicado: (2013)

Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl-2/Bax pathway
por: Li, Jun-Feng, et al.
Publicado: (2017)

Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo
por: Khiste, Sachin K., et al.
Publicado: (2017)

CgGCS, Encoding a Glucosylceramide Synthase, Is Required for Growth, Conidiation and Pathogenicity in Colletotrichum gloeosporioides
por: Huang, Yimei, et al.
Publicado: (2019)

A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to Apoptosis
por: Patwardhan, Gauri A., et al.
Publicado: (2009)

Glucosylceramide synthase regulates hepatocyte repair after concanavalin A-induced immune-mediated liver injury
por: Gan, Jian, et al.
Publicado: (2021)

Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation
por: Li, Zhiqiang, et al.
Publicado: (2021)

Inhibitory Effects of Glucosylceramide on Tumorigenesis Induced by a Carcinogen in Mice
por: Fujiwara, Kazunori, et al.
Publicado: (2019)

Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis
por: Igarashi, Tami, et al.
Publicado: (2023)

Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2014)

Defining the glucosylceramide population of C. elegans
por: Xatse, Mark A., et al.
Publicado: (2023)

Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease
por: Ashe, Karen M., et al.
Publicado: (2011)

Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis
por: Mor, Visesato, et al.
Publicado: (2016)

An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells
por: Chiu, Wei-Hsin, et al.
Publicado: (2015)

A chemical genetic screen reveals that iminosugar inhibitors of plant glucosylceramide synthase inhibit root growth in Arabidopsis and cereals
por: Rugen, Michael D., et al.
Publicado: (2018)

The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
por: Mueller, Markus S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dohprl96qf0ve15tkde736uvvh